Kristeen Maniscalco

Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators

Douglas G. Johns, Zhaohui Ao, Diane P. Naselsky et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 102 citations

Cardiac Muscle, Cardiomyopathy, Heart Failure +11

Deletion of the UT receptor gene results in the selective loss of urotensin‐II contractile activity in aortae isolated from UT receptor knockout mice

David J. Behm, Stephen Harrison, Zhaohui Ao et al. · British Journal of Pharmacology · 2003 · 65 citations · Full text

Hypertension, Heart Failure, Cardiovascular Pharmacology +23

Comparison of Soluble Guanylate Cyclase Stimulators and Activators in Models of Cardiovascular Disease Associated with Oxidative Stress

Melissa H. Costell, Nicolas Ancellin, Roberta E. Bernard et al. · Frontiers in Pharmacology · 2012 · 59 citations · Full text

Hypertension, Heart Failure, Cardiovascular Disease +14

Differential Effects of p38 Mitogen-Activated Protein Kinase and Cyclooxygenase 2 Inhibitors in a Model of Cardiovascular Disease

Robert N. Willette, Marianne Eybye, Alan R. Olzinski et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 50 citations

Urotensin-II: a novel systemic hypertensive factor in the cat

Kristeen Maniscalco, Gerald P. Stankus, Alexandra Wibberley et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 42 citations

Hypertension, Urology, Antihypertensive Therapy +3